Current advances in neuronal intranuclear inclusion disease.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 07 12 2022
accepted: 10 02 2023
medline: 15 5 2023
pubmed: 17 2 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

Neuronal intranuclear inclusion disease (NIID) is a rare but probably underdiagnosed neurodegenerative disorder due to pathogenic GGC expansions in the NOTCH2NLC gene. In this review, we summarize recent developments in the inheritance features, pathogenesis, and histopathologic and radiologic features of NIID that subvert the previous perceptions of NIID. GGC repeat sizes determine the age of onset and clinical phenotypes of NIID patients. Anticipation may be absent in NIID but paternal bias is observed in NIID pedigrees. Eosinophilic intranuclear inclusions in skin tissues once considered pathological hallmarks of NIID can also present in other GGC repeat diseases. Diffusion-weighted imaging (DWI) hyperintensity along the corticomedullary junction once considered the imaging hallmark of NIID can frequently be absent in muscle weakness and parkinsonism phenotype of NIID. Besides, DWI abnormalities can appear years after the onset of predominant symptoms and may even disappear completely with disease progression. Moreover, continuous reports of NOTCH2NLC GGC expansions in patients with other neurodegenerative diseases lead to the proposal of a new concept of NOTCH2NLC-related GGC repeat expansion disorders (NRED). However, by reviewing the previous literature, we point out the limitations of these studies and provide evidence that these patients are actually suffering from neurodegenerative phenotypes of NIID.

Identifiants

pubmed: 36795299
doi: 10.1007/s10072-023-06677-0
pii: 10.1007/s10072-023-06677-0
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1881-1889

Informations de copyright

© 2023. Fondazione Società Italiana di Neurologia.

Références

Lindenberg R, Rubinstein LJ, Herman MM, Haydon GB (1968) A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection. Acta Neuropathol 10(1):54–73. https://doi.org/10.1007/BF00690510
doi: 10.1007/BF00690510 pubmed: 4295804
Sone J, Tanaka F, Koike H, Inukai A, Katsuno M, Yoshida M et al (2011) Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Neurology 76(16):1372–6. https://doi.org/10.1212/WNL.0b013e3182166e13
doi: 10.1212/WNL.0b013e3182166e13
Sone J, Kitagawa N, Sugawara E, Iguchi M, Nakamura R, Koike H et al (2014) Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. J Neurol Neurosurg Psychiatr 85(3):354–6. https://doi.org/10.1136/jnnp-2013-306084
doi: 10.1136/jnnp-2013-306084
Ishiura H, Shibata S, Yoshimura J, Suzuki Y, Qu W, Doi K et al (2019) Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet 51(8):1222–32. https://doi.org/10.1038/s41588-019-0458-z
doi: 10.1038/s41588-019-0458-z pubmed: 31332380
Huang XR, Tang BS, Jin P, Guo JF (2022) The phenotypes and mechanisms of NOTCH2NLC-related GGC repeat expansion disorders: a comprehensive review. Mol Neurobiol 59(1):523–34. https://doi.org/10.1007/s12035-021-02616-2
doi: 10.1007/s12035-021-02616-2 pubmed: 34718964
Pearson CE, Nichol Edamura K, Cleary JD (2005) Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 6(10):729–742. https://doi.org/10.1038/nrg1689
doi: 10.1038/nrg1689 pubmed: 16205713
Malik I, Kelley CP, Wang ET, Todd PK (2021) Molecular mechanisms underlying nucleotide repeat expansion disorders. Nat Rev Mol Cell Biol 22(9):589–607. https://doi.org/10.1038/s41580-021-00382-6
doi: 10.1038/s41580-021-00382-6 pubmed: 34140671 pmcid: 9612635
Paulson H (2018) Repeat expansion diseases. Handb Clin Neurol 147:105–123. https://doi.org/10.1016/B978-0-444-63233-3.00009-9
doi: 10.1016/B978-0-444-63233-3.00009-9 pubmed: 29325606 pmcid: 6485936
Tian Y, Wang JL, Huang W, Zeng S, Jiao B, Liu Z et al (2019) Expansion of human-specific GGC repeat in neuronal intranuclear inclusion disease-related disorders. Am J Hum Genet 105(1):166–76. https://doi.org/10.1016/j.ajhg.2019.05.013
doi: 10.1016/j.ajhg.2019.05.013 pubmed: 31178126 pmcid: 6612530
Deng J, Zhou B, Yu J, Han X, Fu J, Li X et al (2022) Genetic origin of sporadic cases and RNA toxicity in neuronal intranuclear inclusion disease. J Med Genet 59(5):462–9. https://doi.org/10.1136/jmedgenet-2020-107649
doi: 10.1136/jmedgenet-2020-107649 pubmed: 33766934
Tian Y, Zhou L, Gao J, Jiao B, Zhang SZ, Xiao Q et al (2022) Clinical features of NOTCH2NLC-related neuronal intranuclear inclusion disease. J Neurol Neurosur Ps. https://doi.org/10.1136/jnnp-2022-329772
doi: 10.1136/jnnp-2022-329772
Cabal-Herrera AM, Tassanakijpanich N, Salcedo-Arellano MJ, Hagerman RJ (2020) Fragile X-associated tremor/ataxia syndrome (FXTAS): pathophysiology and clinical implications. Int J Mol Sci 21(12):4391. https://doi.org/10.3390/ijms21124391
doi: 10.3390/ijms21124391 pubmed: 32575683 pmcid: 7352421
Jiao B, Zhou L, Zhou Y, Weng L, Liao X, Tian Y et al (2020) Identification of expanded repeats in NOTCH2NLC in neurodegenerative dementias. Neurobiol Aging 89:142e1-e7. https://doi.org/10.1016/j.neurobiolaging.2020.01.010
doi: 10.1016/j.neurobiolaging.2020.01.010
Ma D, Tan YJ, Ng ASL, Ong HL, Sim W, Lim WK et al (2020) Association of NOTCH2NLC repeat expansions with Parkinson disease. JAMA Neurol 77(12):1559–1563. https://doi.org/10.1001/jamaneurol.2020.3023
doi: 10.1001/jamaneurol.2020.3023 pubmed: 32852534
Yuan Y, Liu Z, Hou X, Li W, Ni J, Huang L et al (2020) Identification of GGC repeat expansion in the NOTCH2NLC gene in amyotrophic lateral sclerosis. Neurology 95(24):e3394–e405.  https://doi.org/10.1212/WNL.0000000000010945
doi: 10.1212/WNL.0000000000010945
Shi CH, Fan Y, Yang J, Yuan YP, Shen S, Liu F et al (2021) NOTCH2NLC intermediate-length repeat expansions are associated with Parkinson disease. Ann Neurol 89(1):182–7. https://doi.org/10.1002/ana.25925
doi: 10.1002/ana.25925 pubmed: 33016348
Chen H, Lu L, Wang B, Cui G, Wang X, Wang Y et al (2020) Re-defining the clinicopathological spectrum of neuronal intranuclear inclusion disease. Ann Clin Transl Neurol 7(10):1930–41. https://doi.org/10.1002/acn3.51189
doi: 10.1002/acn3.51189 pubmed: 32931652 pmcid: 7545592
Fukuda H, Yamaguchi D, Nyquist K, Yabuki Y, Miyatake S, Uchiyama Y et al (2021) Father-to-offspring transmission of extremely long NOTCH2NLC repeat expansions with contractions: genetic and epigenetic profiling with long-read sequencing. Clin Epigenetics 13(1):204. https://doi.org/10.1186/s13148-021-01192-5
doi: 10.1186/s13148-021-01192-5 pubmed: 34774111 pmcid: 8590777
Boivin M, Charlet-Berguerand N (2022) Trinucleotide CGG repeat diseases: an expanding field of polyglycine proteins? Front Genet 13:843014. https://doi.org/10.3389/fgene.2022.843014
doi: 10.3389/fgene.2022.843014 pubmed: 35295941 pmcid: 8918734
Ridley RM, Frith CD, Crow TJ, Conneally PM (1988) Anticipation in Huntington’s disease is inherited through the male line but may originate in the female. J Med Genet 25(9):589–595. https://doi.org/10.1136/jmg.25.9.589
doi: 10.1136/jmg.25.9.589 pubmed: 2972838 pmcid: 1051535
Orr HT, Chung MY, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL et al (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 4(3):221–226. https://doi.org/10.1038/ng0793-221
doi: 10.1038/ng0793-221 pubmed: 8358429
Reyniers E, Vits L, De Boulle K, Van Roy B, Van Velzen D, de Graaff E et al (1993) The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat Genet 4(2):143–146. https://doi.org/10.1038/ng0693-143
doi: 10.1038/ng0693-143 pubmed: 8348152
Yu J, Deng J, Guo X, Shan J, Luan X, Cao L et al (2021) The GGC repeat expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy type 3. Brain 144(6):1819–1832. https://doi.org/10.1093/brain/awab077
doi: 10.1093/brain/awab077 pubmed: 33693509 pmcid: 8320266
Fiddes IT, Lodewijk GA, Mooring M, Bosworth CM, Ewing AD, Mantalas GL et al (2018) Human-specific NOTCH2NL genes affect Notch signaling and cortical neurogenesis. Cell. 173(6):1356–1369. https://doi.org/10.1016/j.cell.2018.03.051
doi: 10.1016/j.cell.2018.03.051 pubmed: 29856954 pmcid: 5986104
Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K et al (2019) Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet 51(8):1215–1221. https://doi.org/10.1038/s41588-019-0459-y
doi: 10.1038/s41588-019-0459-y pubmed: 31332381
Krzyzosiak WJ, Sobczak K, Wojciechowska M, Fiszer A, Mykowska A, Kozlowski P (2012) Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res 40(1):11–26. https://doi.org/10.1093/nar/gkr729
doi: 10.1093/nar/gkr729 pubmed: 21908410
Zhong S, Lian Y, Luo W, Luo R, Wu X, Ji J et al (2021) Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases. Acta Neuropathol 142(6):1003–1023. https://doi.org/10.1007/s00401-021-02375-3
doi: 10.1007/s00401-021-02375-3 pubmed: 34694469
Yu J, Liufu T, Zheng Y, Xu J, Meng L, Zhang W et al (2022) CGG repeat expansion in NOTCH2NLC causes mitochondrial dysfunction and progressive neurodegeneration in Drosophila model. Proc Natl Acad Sci USA. 119(41):e2208649119.  https://doi.org/10.1073/pnas.2208649119
Liu Q, Zhang K, Kang Y, Li Y, Deng P, Li Y et al (2022) Expression of expanded GGC repeats within NOTCH2NLC causes behavioral deficits and neurodegeneration in a mouse model of neuronal intranuclear inclusion disease. Sci Adv. 8(47):eadd6391. https://doi.org/10.1126/sciadv.add6391
doi: 10.1126/sciadv.add6391 pubmed: 36417528 pmcid: 9683706
Asamitsu S, Yabuki Y, Ikenoshita S, Kawakubo K, Kawasaki M, Usuki S et al (2021) CGG repeat RNA G-quadruplexes interact with FMRpolyG to cause neuronal dysfunction in fragile X-related tremor/ataxia syndrome. Sci Adv 7(3):eabd9440. https://doi.org/10.1126/sciadv.abd9440
doi: 10.1126/sciadv.abd9440 pubmed: 33523882 pmcid: 7806243
Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S et al (2016) Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain 139(Pt 12):3170–86. https://doi.org/10.1093/brain/aww249
doi: 10.1093/brain/aww249 pubmed: 27797808 pmcid: 5382941
Hunsaker MR, Greco CM, Spath MA, Smits AP, Navarro CS, Tassone F et al (2011) Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol 122(4):467–79. https://doi.org/10.1007/s00401-011-0860-9
doi: 10.1007/s00401-011-0860-9 pubmed: 21785977 pmcid: 3222079
Gokden M, Al-Hinti JT, Harik SI (2009) Peripheral nervous system pathology in fragile X tremor/ataxia syndrome (FXTAS). Neuropathology 29(3):280–4. https://doi.org/10.1111/j.1440-1789.2008.00948.x
doi: 10.1111/j.1440-1789.2008.00948.x
Toko M, Ohshita T, Kurashige T, Morino H, Kume K, Yamashita H et al (2021) FXTAS is difficult to differentiate from neuronal intranuclear inclusion disease through skin biopsy: a case report. BMC Neurol 21(1):396. https://doi.org/10.1186/s12883-021-02425-z
doi: 10.1186/s12883-021-02425-z pubmed: 34641814 pmcid: 8513318
Ogasawara M, Eura N, Nagaoka U, Sato T, Arahata H, Hayashi T et al (2022) Intranuclear inclusions in skin biopsies are not limited to neuronal intranuclear inclusion disease but can also be seen in oculopharyngodistal myopathy. Neuropathol Appl Neurobiol 48(3):e12787. https://doi.org/10.1111/nan.12787
doi: 10.1111/nan.12787 pubmed: 34927285
Ogasawara M, Eura N, Iida A, Kumutpongpanich T, Minami N, Nonaka I et al (2022) Intranuclear inclusions in muscle biopsy can differentiate oculopharyngodistal myopathy and oculopharyngeal muscular dystrophy. Acta Neuropathol Commun 10(1):176. https://doi.org/10.1186/s40478-022-01482-w
doi: 10.1186/s40478-022-01482-w pubmed: 36476314 pmcid: 9727945
Boivin M, Deng J, Pfister V, Grandgirard E, Oulad-Abdelghani M, Morlet B et al (2021) Translation of GGC repeat expansions into a toxic polyglycine protein in NIID defines a novel class of human genetic disorders: the polyG diseases. Neuron 109(11):1825-1835e5. https://doi.org/10.1016/j.neuron.2021.03.038
doi: 10.1016/j.neuron.2021.03.038 pubmed: 33887199 pmcid: 8186563
Abe K, Fujita M (2017) Over 10 years MRI observation of a patient with neuronal intranuclear inclusion disease. BMJ Case Rep 2017. https://doi.org/10.1136/bcr-2016-218790
Wang Y, Wang B, Wang L, Yao S, Zhao J, Zhong S et al (2020) Diagnostic indicators for adult-onset neuronal intranuclear inclusion disease. Clin Neuropathol 39(1):7–18. https://doi.org/10.5414/NP301203
doi: 10.5414/NP301203 pubmed: 31661069
Liu YH, Chou YT, Chang FP, Lee WJ, Guo YC, Chou CT et al (2022) Neuronal intranuclear inclusion disease in patients with adult-onset non-vascular leukoencephalopathy. Brain 145(9):3010–3021. https://doi.org/10.1093/brain/awac135
doi: 10.1093/brain/awac135 pubmed: 35411397
Yokoi S, Yasui K, Hasegawa Y, Niwa K, Noguchi Y, Tsuzuki T et al (2016) Pathological background of subcortical hyperintensities on diffusion-weighted images in a case of neuronal intranuclear inclusion disease. Clin Neuropathol 35(6):375–380. https://doi.org/10.5414/NP300961
doi: 10.5414/NP300961 pubmed: 27719745
Chen L, Wu L, Li S, Huang Q, Xiong J, Hong D et al (2018) A long time radiological follow-up of neuronal intranuclear inclusion disease: two case reports. Medicine (Baltimore) 97(49):e13544. https://doi.org/10.1097/MD.0000000000013544
doi: 10.1097/MD.0000000000013544 pubmed: 30544465
Kawarabayashi T, Nakamura T, Seino Y, Hirohata M, Mori F, Wakabayashi K et al (2018) Disappearance of MRI imaging signals in a patient with neuronal intranuclear inclusion disease. J Neurol Sci 388:1–3. https://doi.org/10.1016/j.jns.2018.02.038
doi: 10.1016/j.jns.2018.02.038 pubmed: 29626999
Eisenmenger L, Porter MC, Carswell CJ, Thompson A, Mead S, Rudge P et al (2016) Evolution of diffusion-weighted magnetic resonance imaging signal abnormality in sporadic Creutzfeldt-Jakob disease, with histopathological correlation. JAMA Neurol 73(1):76–84. https://doi.org/10.1001/jamaneurol.2015.3159
doi: 10.1001/jamaneurol.2015.3159 pubmed: 26569479 pmcid: 5837002
Sugiyama A, Sato N, Kimura Y, Maekawa T, Enokizono M, Saito Y et al (2017) MR imaging features of the cerebellum in adult-onset neuronal intranuclear inclusion disease: 8 cases. AJNR Am J Neuroradiol 38(11):2100–4. https://doi.org/10.3174/ajnr.A5336
doi: 10.3174/ajnr.A5336 pubmed: 28818825 pmcid: 7963582
Sun QY, Xu Q, Tian Y, Hu ZM, Qin LX, Yang JX et al (2020) Expansion of GGC repeat in the human-specific NOTCH2NLC gene is associated with essential tremor. Brain 143(1):222–233. https://doi.org/10.1093/brain/awz372
doi: 10.1093/brain/awz372 pubmed: 31819945
Liao YC, Chang FP, Huang HW, Chen TB, Chou YT, Hsu SL et al (2022) GGC repeat expansion of NOTCH2NLC in Taiwanese patients with inherited neuropathies. Neurology 98(2):e199–e206. https://doi.org/10.1212/WNL.0000000000013008
doi: 10.1212/WNL.0000000000013008
Ogasawara M, Iida A, Kumutpongpanich T, Ozaki A, Oya Y, Konishi H et al (2020) CGG expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy with neurological manifestations. Acta Neuropathol Commun 8(1):204. https://doi.org/10.1186/s40478-020-01084-4
doi: 10.1186/s40478-020-01084-4 pubmed: 33239111 pmcid: 7690190
Westenberger A, Klein C (2020) Essential phenotypes of NOTCH2NLC-related repeat expansion disorder. Brain 143(1):5–8. https://doi.org/10.1093/brain/awz404
doi: 10.1093/brain/awz404 pubmed: 31886491
Ng ASL, Lim WK, Xu Z, Ong HL, Tan YJ, Sim WY et al (2020) NOTCH2NLC GGC repeat expansions are associated with sporadic essential tremor: variable disease expressivity on long-term follow-up. Ann Neurol 88(3):614–8. https://doi.org/10.1002/ana.25803
doi: 10.1002/ana.25803 pubmed: 32495371
Chen H, Lu L, Wang B, Hua X, Wan B, Sun M et al (2020) Essential tremor as the early symptom of NOTCH2NLC gene-related repeat expansion disorder. Brain 143(7):e56. https://doi.org/10.1093/brain/awaa142
doi: 10.1093/brain/awaa142 pubmed: 32449905
Yang D, Cen Z, Wang L, Chen X, Liu P, Wang H et al (2022) Neuronal intranuclear inclusion disease tremor-dominant subtype: a mimicker of essential tremor. Eur J Neurol 29(2):450–8. https://doi.org/10.1111/ene.15169
doi: 10.1111/ene.15169 pubmed: 34750918
Vermilion J, Johnson M, Srinivasan J, Mink JW (2019) Neuronal intranuclear inclusion disease: longitudinal case report of motor and nonmotor symptoms. J Child Neurol 34(13):801–5. https://doi.org/10.1177/0883073819860566
doi: 10.1177/0883073819860566 pubmed: 31304825 pmcid: 6801045
Wang ZY, Guo JJ, Wang M, Wang ZX, Hong DJ, Yu XF (2020) Adult-onset neuronal intranuclear inclusion disease mimicking Parkinson’s disease in a Chinese patient: a case report and literature reviews. Neuro Endocrinol Lett 41(4):155–161
pubmed: 33307649
Paviour DC, Revesz T, Holton JL, Evans A, Olsson JE, Lees AJ (2005) Neuronal intranuclear inclusion disease: report on a case originally diagnosed as dopa-responsive dystonia with Lewy bodies. Mov Disord 20(10):1345–1349. https://doi.org/10.1002/mds.20559
doi: 10.1002/mds.20559 pubmed: 15966005
Liu P, Yang D, Zhang F, Chen S, Xie F, Luo Y et al (2022) The role of NOTCH2NLC in Parkinson’s disease: a clinical, neuroimaging, and pathological study. Eur J Neurol 29(6):1610–8. https://doi.org/10.1111/ene.15283
doi: 10.1111/ene.15283 pubmed: 35147270
Sugiyama A, Takeda T, Koide M, Yokota H, Mukai H, Kitayama Y et al (2021) Coexistence of neuronal intranuclear inclusion disease and amyotrophic lateral sclerosis: an autopsy case. BMC Neurol 21(1):273. https://doi.org/10.1186/s12883-021-02306-5
doi: 10.1186/s12883-021-02306-5 pubmed: 34243731 pmcid: 8268606
Mann DM, Rollinson S, Robinson A, Bennion Callister J, Thompson JC, Snowden JS et al (2013) Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol Commun 1:68. https://doi.org/10.1186/2051-5960-1-68
doi: 10.1186/2051-5960-1-68 pubmed: 24252525 pmcid: 3893586
Lee SM, Asress S, Hales CM, Gearing M, Vizcarra JC, Fournier CN et al (2019) TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis/frontotemporal lobar degeneration. Brain Commun 1(1):fcz014. https://doi.org/10.1093/braincomms/fcz014
doi: 10.1093/braincomms/fcz014 pubmed: 31633109 pmcid: 6788139
Davidson JM, Chung RS, Lee A (2022) The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Neurobiol Dis 166:105653. https://doi.org/10.1016/j.nbd.2022.105653
doi: 10.1016/j.nbd.2022.105653 pubmed: 35143965
Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I et al (2011) p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol 122(6):691–702. https://doi.org/10.1007/s00401-011-0911-2
doi: 10.1007/s00401-011-0911-2 pubmed: 22101323
Fan Y, Xu Y, Shi C (2022) NOTCH2NLC-related disorders: the widening spectrum and genotype-phenotype correlation. J Med Genet 59(1):1–9. https://doi.org/10.1136/jmedgenet-2021-107883
doi: 10.1136/jmedgenet-2021-107883 pubmed: 34675123
Sone J, Hishikawa N, Koike H, Hattori N, Hirayama M, Nagamatsu M et al (2005) Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy. Neurology 65(10):1538–1543. https://doi.org/10.1212/01.wnl.0000184490.22527.90
doi: 10.1212/01.wnl.0000184490.22527.90

Auteurs

Lei Bao (L)

Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.
Department of Neurology, Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.

Dandan Zuo (D)

Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.

Qingjie Li (Q)

Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.

Hao Chen (H)

Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China. haochen-2008@hotmail.com.

Guiyun Cui (G)

Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China. cuiguiyun56@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH